Detailed information for compound 1625561

Basic information

Technical information
  • TDR Targets ID: 1625561
  • Name: 2-(2-methylphenyl)-2,3-dihydrochromeno[3,2-e] pyrimidin-4-one
  • MW: 290.316 | Formula: C18H14N2O2
  • H donors: 1 H acceptors: 1 LogP: 3.24 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1NC(N=C2C1=Cc1ccccc1O2)c1ccccc1C
  • InChi: 1S/C18H14N2O2/c1-11-6-2-4-8-13(11)16-19-17(21)14-10-12-7-3-5-9-15(12)22-18(14)20-16/h2-10,16H,1H3,(H,19,21)
  • InChiKey: ALLSYZMZJAHIPJ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 75586-35-5
  • 2-(2-Methylphenyl)-2,3-dihydro-4H-chromeno[2,3-d]pyrimidin-4-one
  • 2-(2-Methylphenyl)-2,3-dihydro-4H-chromeno(2,3-d)pyrimidin-4-one
  • NSC 336032
  • AIDS015800
  • 4H-[1]Benzopyrano[2,3-d]pyrimidine-4-one der.
  • AIDS-015800
  • 4H-[1]Benzopyrano[2,3-d]pyrimidine-4-one, 2,3-dihydro-2-(2-methylphenyl)-
  • NSC336032

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glucagon-like peptide 1 receptor Starlite/ChEMBL No references
Homo sapiens apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) pigment dispersing factor receptor c glucagon-like peptide 1 receptor 463 aa 388 aa 25.8 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Brugia malayi hypothetical protein 0.0182 0.1282 0.1282
Onchocerca volvulus 0.0182 0.1282 1
Trichomonas vaginalis TKL family protein kinase 0.0022 0 0.5
Giardia lamblia Kinase, NEK 0.0022 0 0.5
Schistosoma mansoni hypothetical protein 0.0041 0.0156 0.0156
Loa Loa (eye worm) hypothetical protein 0.0041 0.0156 0.0156
Trichomonas vaginalis TKL family protein kinase 0.0022 0 0.5
Echinococcus granulosus integrin linked protein kinase 0.1276 1 1
Schistosoma mansoni protein kinase 0.1276 1 1
Entamoeba histolytica protein kinase, putative 0.0022 0 0.5
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.006 0.0307 0.0307
Entamoeba histolytica ankyrin repeat protein 0.0022 0 0.5
Loa Loa (eye worm) pigment dispersing factor receptor c 0.006 0.0307 0.0307
Brugia malayi Calcitonin receptor-like protein seb-1 0.006 0.0307 0.0307
Entamoeba histolytica protein kinase, putative 0.0022 0 0.5
Loa Loa (eye worm) hypothetical protein 0.006 0.0307 0.0307
Trichomonas vaginalis TKL family protein kinase 0.0022 0 0.5
Loa Loa (eye worm) TKL/MLK/ILK protein kinase 0.1276 1 1
Loa Loa (eye worm) hypothetical protein 0.0182 0.1282 0.1282
Trichomonas vaginalis ankyrin repeat-containing protein, putative 0.0022 0 0.5
Brugia malayi latrophilin 2 splice variant baaae 0.0041 0.0156 0.0156
Schistosoma mansoni protein kinase 0.1276 1 1
Echinococcus multilocularis integrin linked protein kinase 0.1276 1 1
Trichomonas vaginalis TKL family protein kinase 0.0022 0 0.5
Giardia lamblia Protein 21.1 0.0022 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 0.8913 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 2.8184 uM PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 22.3872 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.